Home › NCT06342284

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer: A Pilot Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
* Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
* Concurrent chemotherapy is permitted but not required..
* Previous thoracic radiotherapy is allowed.
* Ability to complete study surveys in English or Spanish
* Age \>/= 18
* Concurrent enrollment on other trials is permitted
* Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
* All patients must sign study-specific informed consent prior to study entry

Exclusion Criteria:

* Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
* Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

About the study

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

What is being tested

• Proton Beam Radiation with or without concurrent chemotherapy (radiation)

Sponsor: The New York Proton Center · Participants: 40 · Started: Mar 22, 2024

Contact the study team

• Nitin Ohri, MD · Phone: 718-405-8550
• Ryan Holder, BS · Phone: 646-968-9055

Official record on ClinicalTrials.gov — NCT06342284

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.